Tetralogic Pharmaceuticals Corp Share Price Nasdaq
Equities
US88165U1097
Biotechnology & Medical Research
Sales 2014 | - | Sales 2015 | - | Capitalization | 42.07M 3.37B |
---|---|---|---|---|---|
Net income 2014 | -36M -2.89B | Net income 2015 | -49M -3.93B | EV / Sales 2014 | - |
Net cash position 2014 | 22.32M 1.79B | Net Debt 2015 | 7.92M 635M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.96
x | P/E ratio 2015 |
-0.82
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 31/01/14 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 31/10/12 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |